Despite the introduction of new antiemetic agents, short-actinganesthetics, and minimally invasive surgical techniques, theincidence of postoperative nausea and vomiting has remainedlargely unchanged over the past two decades.1 The high incidenceof postoperative nausea and vomiting has persisted in part becauseof the tremendous growth in ambulatory surgery and the increasedemphasis on earlier mobilization and discharge after both minorand major operations.
Prophylactic use of antiemetics has become the standard approachto minimizing emetic symptoms after surgery because patientsare more satisfied with this approach than with the treatmentof symptoms when they occur in the postoperative . . . [Full Text of this Article]
Source Information
From the Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center, Dallas.
This article has been cited by other articles:
Gan, T. J., Sinha, A. C., Kovac, A. L., Jones, R. K., Cohen, S. A., Battikha, J. P., Deutsch, J. S., Pergolizzi, J. V. Jr, the TDS Study Group, , Glass, P. S. A.
(2009). A Randomized, Double-Blind, Multicenter Trial Comparing Transdermal Scopolamine Plus Ondansetron to Ondansetron Alone for the Prevention of Postoperative Nausea and Vomiting in the Outpatient Setting. Anesth. Analg.
108: 1498-1504
[Abstract][Full Text]
White, P. F., O'Hara, J. F., Roberson, C. R., Wender, R. H., Candiotti, K. A., The POST-OP Study Group,
(2008). The Impact of Current Antiemetic Practices on Patient Outcomes: A Prospective Study on High-Risk Patients. Anesth. Analg.
107: 452-458
[Abstract][Full Text]
White, P. F., Sacan, O., Nuangchamnong, N., Sun, T., Eng, M. R.
(2008). The Relationship Between Patient Risk Factors and Early Versus Late Postoperative Emetic Symptoms. Anesth. Analg.
107: 459-463
[Abstract][Full Text]
White, P. F., Glass, P. S. A.
(2008). Universal PONV Prophylaxis in General Anesthesia: Should We Consider Its Immediate Implementation?. Anesth. Analg.
106: 1922-1923
[Full Text]
Kapoor, R., Hola, E. T., Adamson, R. T., Mathis, A. S.
(2008). Comparison of two instruments for assessing risk of postoperative nausea and vomiting. Am J Health Syst Pharm
65: 448-453
[Abstract][Full Text]
Chen, C.-C., Lin, C.-S., Ko, Y.-P., Hung, Y.-C., Lao, H.-C., Hsu, Y.-W.
(2008). Premedication with Mirtazapine Reduces Preoperative Anxiety and Postoperative Nausea and Vomiting. Anesth. Analg.
106: 109-113
[Abstract][Full Text]
White, P. F., Kehlet, H., Neal, J. M., Schricker, T., Carr, D. B., Carli, F., the Fast-Track Surgery Study Group,
(2007). The Role of the Anesthesiologist in Fast-Track Surgery: From Multimodal Analgesia to Perioperative Medical Care. Anesth. Analg.
104: 1380-1396
[Abstract][Full Text]
White, P. F.
(2007). Use of Alternative Medical Therapies in the Perioperative Period: Is It Time to Get on Board?. Anesth. Analg.
104: 251-254
[Full Text]
White, P. F., Tang, J., Song, D., Coleman, J. E., Wender, R. H., Ogunnaike, B., Sloninsky, A., Kapu, R., Shah, M., Webb, T.
(2007). Transdermal Scopolamine: An Alternative to Ondansetron and Droperidol for the Prevention of Postoperative and Postdischarge Emetic Symptoms. Anesth. Analg.
104: 92-96
[Abstract][Full Text]
Piper, S. N., Rohm, K. D., Boldt, J., Faust, K. L., Maleck, W. H., Kranke, P., Suttner, S. W.
(2006). Inspired oxygen fraction of 0.8 compared with 0.4 does not further reduce postoperative nausea and vomiting in dolasetron-treated patients undergoing laparoscopic cholecystectomy. Br J Anaesth
97: 647-653
[Abstract][Full Text]
White, P. F., Tang, J., Hamza, M. A., Ogunnaike, B., Lo, M., Wender, R. H., Naruse, R., Sloninsky, A., Kariger, R., Cunneen, S., Khalili, T.
(2006). The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery.. Anesth. Analg.
102: 1387-1393
[Abstract][Full Text]
White, P. F., Hamza, M. A., Recart, A., Coleman, J. E., Macaluso, A. R., Cox, L., Jaffer, O., Song, D., Rohrich, R.
(2005). Optimal Timing of Acustimulation for Antiemetic Prophylaxis as an Adjunct to Ondansetron in Patients Undergoing Plastic Surgery. Anesth. Analg.
100: 367-372
[Abstract][Full Text]